Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Lung Cancer (Amsterdam, Netherlands)|February 9, 2020
Positive EGFR mutation status is a risk of recurrence in pN0-1 lung adenocarcinoma when combined with pathological stage and histological subtype: A retrospective multi-center analysisMasaoki Ito, Yoshihiro Miyata, Yasuhiro Tsutani, et al.
The Annals of Thoracic Surgery|January 26, 2020
Solid Tumor Size of 2 cm Divides Outcomes of Patients With Mixed Ground Glass Opacity Lung TumorsTakahiro Mimae, Yasuhiro Tsutani, Yoshihiro Miyata, et al.
Japanese Journal of Clinical Oncology|June 25, 2020
Wedge resection as an alternative treatment for octogenarian and older patients with early-stage non-small-cell lung cancerTakahiro Mimae, Yoshihiro Miyata, Yasuhiro Tsutani, et al.
Cureus|March 26, 2025
Predictive Role of Lymph Node Germinal Centers in Postoperative Recurrence of Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor TherapyYohei Kawaguchi, Munehide Nakatsugawa, Nanako Nishioka, et al.
Journal of Thoracic Disease|February 13, 2019
Prognostic value of tumor solid-part size and solid-part volume in patients with clinical stage I non-small cell lung cancerYoshihisa Shimada, Hideyuki Furumoto, Kentaro Imai, et al.
Clinical Genitourinary Cancer|May 3, 2023
Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Renal Cell Carcinoma Post-nephrectomy in the United StatesYizhen Lai, Arielle G Bensimon, Emily Gao, et al.
Japanese Journal of Clinical Oncology|July 31, 2021
Risk of death due to other causes is lower among octogenarians with non-small cell lung cancer after wedge resection than lobectomy/segmentectomyTakahiro Mimae, Yoshihiro Miyata, Kenichi Yoshimura, et al.
Future Oncology (London, England)|February 12, 2025
Patient preferences for adjuvant therapy in renal cell carcinoma: a discrete-choice experimentShawna R Calhoun, Caroline Vass, Kelley Myers, et al.
Internal Medicine (Tokyo, Japan)|March 2, 2013
Hemophagocytic syndrome in an acute human immunodeficiency virus infectionEisuke Adachi, Tomohiko Koibuchi, Kentaro Imai, et al.
Future Oncology (London, England)|February 13, 2025
Oncologists' and urologists' preferences for adjuvant therapy in renal cell carcinoma: a discrete-choice experimentCaroline Vass, Cathy Anne Pinto, Kelley Myers, et al.
Pageof 7